ACIMD-ISIEM 2027
24 – 27 March 2027
Dear Colleagues,
On behalf of the Organizing Committee, it is our great pleasure to welcome you to the 7 Asian Congress on Inherited Metabolic Diseases (ACIMD 2027) together with the 8 Conference of the Indian Society for Inborn Errors of Metabolism (ISIEM), to be held from 24 to 27 March 2027 in JW Marriott Aerocity New Delhi, India.
With the theme "Innovate, Collaborate, Transform: Advancing Care of Inherited Metabolic Disorders in Asia," ACIMD-ISIEM 2027 aims to bring together leading clinicians, scientists, laboratory specialists, geneticists, dietitians, researchers, trainees, industry partners, and patient organizations from across Asia and around the world to exchange knowledge, foster collaborations, and advance the care of IMDs. The scientific programme has been carefully designed to showcase the latest advances across the entire spectrum of inherited metabolic medicine. The Congress will feature internationally renowned keynote and plenary speakers, interactive scientific sessions, Spotlight Asia presentations, Young Investigator sessions, oral and poster presentations, key opinion leader interactions, and opportunities for networking and collaborative research.
Scientific highlights include:
- Current Perspectives in Newborn Screening
- Multi-omics, Precision Diagnostics & Long-read Sequencing
- Metabolic Neuro-Radiology
- Advances in the Treatment of Inherited Metabolic Disorders (Gene Therapy, Genome Editing & Novel Therapeutics)
- Emerging and established concepts in cellular metabolism
- Artificial Intelligence & Digital Health
- Precision Nutrition & Dietary Management
- Adult-Onset IMDs
- Government initiatives for care in IMDs
In addition, pre-conference workshops will provide practical, hands-on learning in Newborn Screening, Dietary (metobolic nutritionist) Management of Inherited Metabolic Disorders, and Multi-omics for Precision Diagnosis of IMDs, offering participants valuable skills that can be translated directly into clinical practice and research. ACIMD 2027 is envisioned as a platform to showcase scientific excellence, encourage multidisciplinary collaboration, strengthen research partnerships across Asia, and inspire innovative approaches that improve outcomes for individuals and families living with inherited metabolic disorders. Beyond the scientific programme, New Delhi offers a unique blend of rich cultural heritage, warm hospitality, and modern infrastructure, providing the perfect setting to reconnect with colleagues, establish new collaborations, and celebrate the progress being made in inherited metabolic medicine. We warmly invite you to join us in New Delhi and be part of this exciting scientific journey. Together, let us innovate, collaborate, and transform the future of inherited metabolic disorders across Asia.
We look forward to welcoming you to ACIMD 2027.
